All together, the BMI1-induced repression of Runx1 and Pten may convey a more malignant phenotype in those abnormal haematopoietic stem/progenitor clones, leading to malignant myeloid progression in MDS or CML-CP. The gene discussed is RUNX1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.